CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Total
Balance at beginning of period at Dec. 31, 2020	$ 235	$ 154,866	$ (62,927)	$ (1,200)	$ 90,974
Balance at beginning of period (in shares) at Dec. 31, 2020	23,526,517
Increase (Decrease) in Stockholders' Equity
Net loss			(5,228)		(5,228)
Unrealized income (loss) on foreign exchange rate translation				201	201
Stock-based compensation expense		101			101
Balance at end of period at Mar. 31, 2021	$ 235	154,967	(68,155)	(999)	86,048
Balance at end of period (in shares) at Mar. 31, 2021	23,526,517
Balance at beginning of period at Dec. 31, 2020	$ 235	154,866	(62,927)	(1,200)	90,974
Balance at beginning of period (in shares) at Dec. 31, 2020	23,526,517
Increase (Decrease) in Stockholders' Equity
Net loss					(22,110)
Balance at end of period at Sep. 30, 2021	$ 237	155,101	(85,037)	(1,095)	69,206
Balance at end of period (in shares) at Sep. 30, 2021	23,692,379
Balance at beginning of period at Mar. 31, 2021	$ 235	154,967	(68,155)	(999)	86,048
Balance at beginning of period (in shares) at Mar. 31, 2021	23,526,517
Increase (Decrease) in Stockholders' Equity
Net loss			(9,017)		(9,017)
Unrealized income (loss) on foreign exchange rate translation				211	211
Issuance of common stock under stock compensation plans	$ 2	(2)
Issuance of common stock under stock compensation plans (in shares)	174,000
Stock-based compensation expense		67			67
Issuance of common stock as compensation		30			30
Issuance of common stock as compensation (in shares)	11,320
Shares exchanged for taxes on stock-based compensation		(75)			(75)
Shares exchanged for taxes on stock-based compensation (in shares)	(31,410)
Balance at end of period at Jun. 30, 2021	$ 237	154,987	(77,172)	(788)	77,264
Balance at end of period (in shares) at Jun. 30, 2021	23,680,427
Increase (Decrease) in Stockholders' Equity
Net loss			(7,865)		(7,865)
Unrealized income (loss) on foreign exchange rate translation				(307)	(307)
Stock-based compensation expense		84			84
Issuance of common stock as compensation		30			30
Issuance of common stock as compensation (in shares)	11,952
Balance at end of period at Sep. 30, 2021	$ 237	155,101	(85,037)	(1,095)	69,206
Balance at end of period (in shares) at Sep. 30, 2021	23,692,379
Balance at beginning of period at Dec. 31, 2021	$ 237	155,268	(92,018)	(1,010)	$ 62,477
Balance at beginning of period (in shares) at Dec. 31, 2021	23,692,379				23,643,934
Increase (Decrease) in Stockholders' Equity
Net loss			(2,391)		$ (2,391)
Unrealized income (loss) on foreign exchange rate translation				(233)	(233)
Issuance of common stock under stock compensation plans	$ 1	(1)
Issuance of common stock under stock compensation plans (in shares)	155,000
Stock-based compensation expense		279			279
Treasury Stock Sale		113			113
Shares exchanged for taxes on stock-based compensation		(79)			(79)
Shares exchanged for taxes on stock-based compensation (in shares)	(35,050)
Balance at end of period at Mar. 31, 2022	$ 238	155,580	(94,409)	(1,243)	60,166
Balance at end of period (in shares) at Mar. 31, 2022	23,812,329
Balance at beginning of period at Dec. 31, 2021	$ 237	155,268	(92,018)	(1,010)	$ 62,477
Balance at beginning of period (in shares) at Dec. 31, 2021	23,692,379				23,643,934
Increase (Decrease) in Stockholders' Equity
Net loss					$ (17,672)
Balance at end of period at Sep. 30, 2022	$ 238	155,413	(109,690)	(2,248)	$ 43,713
Balance at end of period (in shares) at Sep. 30, 2022	23,812,329				23,812,329
Balance at beginning of period at Mar. 31, 2022	$ 238	155,580	(94,409)	(1,243)	$ 60,166
Balance at beginning of period (in shares) at Mar. 31, 2022	23,812,329
Increase (Decrease) in Stockholders' Equity
Net loss			(7,678)		(7,678)
Unrealized income (loss) on foreign exchange rate translation				(439)	(439)
Stock-based compensation expense		89			89
Balance at end of period at Jun. 30, 2022	$ 238	155,669	(102,087)	(1,682)	52,138
Balance at end of period (in shares) at Jun. 30, 2022	23,812,329
Increase (Decrease) in Stockholders' Equity
Net loss			(7,603)		(7,603)
Cash settlement of RSUs		(301)			(301)
Unrealized income (loss) on foreign exchange rate translation				(566)	(566)
Stock-based compensation expense		45			45
Balance at end of period at Sep. 30, 2022	$ 238	$ 155,413	$ (109,690)	$ (2,248)	$ 43,713
Balance at end of period (in shares) at Sep. 30, 2022	23,812,329				23,812,329